key: cord-0075858-rj0biu5o
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Correspondence on “hypermetabolic axillary lymph nodes in oncologic patients and COVID-19 vaccination”
date: 2022-03-19
journal: J Med Imaging Radiat Sci
DOI: 10.1016/j.jmir.2022.03.001
sha: 59157299123ce7cc51ed860c3ad7326c0667f3e8
doc_id: 75858
cord_uid: rj0biu5o

nan

We would like to share ideas on the publication "Intensity of hypermetabolic axillary lymph nodes in oncologic patients in relation to timeline following COVID-19 vaccination [1] ." Su et al. concluded that "Based on our preliminary results, we would recommend correlation with a history and time of vaccination and routine use of a pre-study patient questionnaire to guide interpretation to ….in oncologic patients [1] ." We agree that COVID-19 vaccination can elicit a variety of physiological reactions, including adenopathy. For lymphadenopathy, an ipsilateral lymphadenopathy could be present in this situation. However, according to the current data, atypical lymphadenopathy, rather than unilateral ipsilateral adenopathy, can occur in up to 7% of cases [2] . Furthermore, we must be aware of the likelihood of a concomitant medical problem that could be overlooked [3] . According to Su et al., cautious interpretation is required to avoid false positives following immunization. A period of time should be allowed between immunization and adenopathy study [3] .

Dr DY Patil University, Pune, India

Intensity of hypermetabolic axillary lymph nodes in oncologic patients in relation to timeline following COVID-19 vaccination

Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features

Online ahead of print